Each filer's latest filing for M40527109 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Biotechnology Value Fund L P
13D
|
10.0% |
8/4/2026
Event 7/28/2026
|
||
| Biotechnology Value Fund L P | 5.3% | |||
| BVF I GP LLC | 5.3% | |||
| Biotechnology Value Fund II LP | 3.9% | |||
| BVF II GP LLC | 3.9% | |||
| Biotechnology Value Trading Fund OS LP | 0.7% | |||
| BVF Partners OS Ltd. | 0.7% | |||
| BVF GP Holdings LLC | 9.2% | |||
| BVF Partners L P/IL | 10.0% | |||
| BVF Inc/IL | 10.0% | |||
| Lampert Mark N | 10.0% | |||
| Opko Health, Inc. 13G | 8.1% |
4/2/2025
Event 3/16/2025
|
||
|
TCG Crossover GP III, LLC
13G
|
7.1% |
8/4/2026
Event 7/28/2026
|
||
| TCG Crossover GP III, LLC | 7.1% | |||
| TCG Crossover Fund III, L.P. | 7.1% | |||
| Chen Yu | 7.1% | |||
|
Vivo Opportunity Fund Holdings, L.P.
13G
|
6.9% |
8/4/2026
Event 7/28/2026
|
||
| Vivo Opportunity Fund Holdings, L.P. | 2.5% | |||
| Vivo Opportunity Co-Invest, L.P. | 1.6% | |||
| Vivo Opportunity Co-Invest (Cycle 3), L.P. | 2.8% | |||
| Vivo Opportunity, LLC | 6.9% | |||
| Vivo Opportunity Cayman Fund, L.P. | 0.3% | |||
| Vivo Opportunity Cayman, LLC | 0.3% | |||
|
Spruce Street Capital LP
13G
|
6.4% |
11/13/2026
Event 9/30/2026
|
||
| Spruce Street Capital LP | 6.4% | |||
| Alex R. Rosen | 6.4% | |||
| Simon Basseyn | 6.4% | |||
|
Venrock Healthcare Capital Partners III, L.P.
13G
|
5.1% |
10/30/2026
Event 10/23/2026
|
||
| Venrock Healthcare Capital Partners III, L.P. | 5.1% | |||
| VHCP Co-Investment Holdings III, LLC | 5.1% | |||
| Venrock Healthcare Capital Partners EG, L.P. | 5.1% | |||
| VHCP Management III, LLC | 5.1% | |||
| VHCP Management EG, LLC | 5.1% | |||
| Nimish Shah | 5.1% | |||
| Bong Y. Koh | 5.1% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
Longitude Capital Partners V, LLC
13G
|
4.6% |
8/4/2026
Event 7/28/2026
|
||
| Longitude Capital Partners V, LLC | 4.6% | |||
| Longitude Venture Partners V, L.P. | 4.6% | |||
| Patrick G. Enright | 4.6% | |||
| Juliet Tammenoms Bakker | 4.6% | |||
|
Seven Fleet Capital Management LP
13G
|
4.1% |
8/4/2026
Event 7/28/2026
|
||
| Seven Fleet Horizon Master Fund LP | 1.1% | |||
| Seven Fleet Master Fund LP | 3.0% | |||
| Seven Fleet Capital Management LP | 4.1% | |||
| Seven Fleet Capital Management GP LLC | 4.1% | |||
| Brian Liu | 4.1% | |||
|
Point72 Asset Management, L.P.
13G/A
|
2.6% |
11/14/2025
Event 9/30/2025
|
||
| Point72 Asset Management, L.P. | 2.6% | |||
| Point72 Capital Advisors, Inc. | 2.6% | |||
| Steven A. Cohen | 2.6% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 21 | 37.6 M | $109M |
| 2026 Q2 | 27 | 10.7 M | $19.0M |
| 2026 Q1 | 26 | 7.87 M | $8.68M |
| 2025 Q4 | 22 | 9.34 M | $18.1M |
| 2025 Q3 | 22 | 9.19 M | $17.7M |
| 2025 Q2 | 20 | 10.2 M | $19.4M |
| 2025 Q1 | 20 | 10.2 M | $17.4M |
| 2024 Q4 | 15 | 7.49 M | $15.9M |
| 2024 Q3 | 18 | 5.32 M | $10.1M |
| 2024 Q2 | 16 | 5.29 M | $9.75M |
| 2024 Q1 | 16 | 4.26 M | $7.11M |
| 2023 Q4 | 12 | 4.06 M | $2.44M |
| 2023 Q3 | 13 | 2.58 M | $1.87M |
| 2023 Q2 | 13 | 2.57 M | $2.17M |
| 2023 Q1 | 11 | 2.83 M | $3.28M |
| 2022 Q4 | 14 | 3.05 M | $416k |
| 2022 Q3 | 12 | 4.66 M | $4.85M |
| 2022 Q2 | 12 | 4.92 M | $6.54M |
| 2022 Q1 | 14 | 4.95 M | $14.2M |
| 2021 Q4 | 14 | 5.66 M | $15.9M |
| 2021 Q3 | 16 | 5.67 M | $26.7M |
| 2021 Q2 | 16 | 5.11 M | $30.6M |
| 2021 Q1 | 9 | 1.99 M | $7.57M |
| 2020 Q4 | 6 | 1.86 M | $2.01M |
| 2020 Q3 | 7 | 1.91 M | $2.36M |
| 2020 Q2 | 6 | 1.95 M | $3.42M |
| 2020 Q1 | 4 | 1.99 M | $3.78M |
| 2019 Q4 | 4 | 1.92 M | $3.99M |
| 2019 Q3 | 6 | 1.05 M | $2.62M |
| 2019 Q2 | 7 | 1.07 M | $3.49M |
| 2019 Q1 | 8 | 1.09 M | $4.67M |
| 2018 Q4 | 7 | 1.03 M | $3.10M |
| 2018 Q3 | 5 | 769 k | $4.11M |
| 2018 Q2 | 3 | 725 k | $4.57M |